methotrimeprazine has been researched along with risperidone in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 12 (54.55) | 29.6817 |
| 2010's | 8 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Bleich, S; Kornhuber, J; Rupprecht, R; Terfloth, L; Wiltfang, J | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Azorin, JM; Blin, O; Bouhours, P | 1 |
| Honma, H; Koyama, T; Matsubara, S; Suzuki, I; Watanabe, N | 1 |
| Iyo, M; Shimizu, E; Watanabe, H | 1 |
| Fukasawa, T; Hayashi, H; Kawakatsu, S; Otani, K; Watanabe, K | 1 |
| Goto, M; Kaji, K; Kakihara, S; Nakamura, J; Shinkai, K; Ueda, N; Yamada, Y; Yoshimura, R | 1 |
| Baeza, I; Bernardo, M; Lázaro, ML; Mané, A; Morer, A | 1 |
| Bost, M; Bricca, G; Bui-Xuan, B; Descotes, J; Manati, W; Tabib, A; Timour, Q; Turrel, F; Vaillant, F | 1 |
| Engedal, K; Selbaek, G | 1 |
| Belhani, D; Bost, M; Bui-Xuan, B; Descotes, J; Hamdan, L; Maffre, V; Manati, W; Tabib, A; Timour, Q; Vaillant, F | 1 |
| Munhoz, RP; Teive, HA; Werneck, LC | 1 |
| Jayaram, MB; Rattehalli, RD; Sivaraman, P | 1 |
| Akanuma, K; Meguro, K; Meguro, M | 1 |
| Campistol, J; Darling, A; Perez-Duenas, B; Poo, P | 1 |
| Sakamoto, S; Sato, K; Takaki, M; Yamada, N; Yoshimura, B | 1 |
2 review(s) available for methotrimeprazine and risperidone
| Article | Year |
|---|---|
Levomepromazine for schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Methotrimeprazine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2010 |
[Medication-related oculogyric crises: a description of four cases and a review of the literature].
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Child, Preschool; Dopamine; Dopamine Antagonists; Down Syndrome; Dyskinesia, Drug-Induced; Dystonic Disorders; Electroencephalography; Epilepsy; Female; Fragile X Syndrome; Humans; Intellectual Disability; Isoxazoles; Male; Methotrimeprazine; Ocular Motility Disorders; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Risperidone; Substance Withdrawal Syndrome; Translocation, Genetic; Valproic Acid | 2013 |
1 trial(s) available for methotrimeprazine and risperidone
| Article | Year |
|---|---|
Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Methotrimeprazine; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology | 1996 |
19 other study(ies) available for methotrimeprazine and risperidone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.
Topics: Binding Sites; Computer Simulation; Databases, Factual; Models, Chemical; Models, Molecular; Molecular Structure; Molecular Weight; Psychotropic Drugs; Serotonin 5-HT3 Receptor Antagonists; Structure-Activity Relationship | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[A study of neuroleptic malignant syndrome in the presenium and senium].
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Dementia, Vascular; Female; Haloperidol; Humans; Male; Methotrimeprazine; Middle Aged; Neuroleptic Malignant Syndrome; Piperazines; Risperidone; Schizophrenia | 1998 |
Delayed-onset nocturnal akathisia due to risperidone and levomepromazine: a case report.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Circadian Rhythm; Female; Humans; Methotrimeprazine; Middle Aged; Risperidone; Schizophrenia, Paranoid | 2002 |
Neuroleptic malignant syndrome complicated by massive intestinal bleeding in a patient with chronic renal failure.
Topics: Adult; Antipsychotic Agents; Gastrointestinal Hemorrhage; Glomerulonephritis; Humans; Kidney Failure, Chronic; Male; Methotrimeprazine; Mutism; Neuroleptic Malignant Syndrome; Risperidone | 2002 |
Little effects of low dosage of levomepromazine on plasma risperidone levels.
Topics: Adolescent; Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Dose-Response Relationship, Drug; Female; Humans; Male; Methotrimeprazine; Middle Aged; Psychotic Disorders; Risperidone | 2005 |
Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia.
Topics: Administration, Oral; Adolescent; Antipsychotic Agents; Clozapine; Combined Modality Therapy; Electroconvulsive Therapy; Humans; Injections, Intramuscular; Male; Methotrimeprazine; Neuroleptic Malignant Syndrome; Recurrence; Risperidone; Schizophrenia | 2005 |
Role of selenium in heart lesions produced by neuroleptics in the rabbit.
Topics: Animals; Antipsychotic Agents; Down-Regulation; Female; Heart Diseases; Injections, Intramuscular; Kidney; Liver; Methotrimeprazine; Myocardium; Rabbits; Risperidone; Selenium | 2008 |
[Atypical antipsychotics in elderly patients with dementia].
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dementia; Haloperidol; Humans; Methotrimeprazine; Middle Aged; Olanzapine; Risk Factors; Risperidone; Stroke | 2008 |
Protective role of selenium supplementation against cardiac lesions induced by the combination of levomepromazine and risperidone in the rabbit.
Topics: Animals; Antipsychotic Agents; Cardiotonic Agents; Death, Sudden, Cardiac; Female; Fibrosis; Methotrimeprazine; Myocardium; Necrosis; Rabbits; Risperidone; Selenium; Sodium Selenite | 2009 |
The differential diagnoses of parkinsonism: findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics.
Topics: Aged; Antipsychotic Agents; Cinnarizine; Cohort Studies; Diagnosis, Differential; Female; Flunarizine; Haloperidol; Humans; Male; Methotrimeprazine; Movement Disorders; Outpatient Clinics, Hospital; Parkinsonian Disorders; Psychotic Disorders; Risperidone; Severity of Illness Index; Time Factors; Valproic Acid | 2010 |
Recurrent delusional ideas due to left caudate head infarction, without dementia.
Topics: Aged; Antipsychotic Agents; Brain; Cerebral Infarction; Cerebrovascular Circulation; Delusions; Dementia; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Methotrimeprazine; Recurrence; Risperidone; Tomography, Emission-Computed, Single-Photon | 2012 |
Predictors of remission during acute treatment of first-episode schizophrenia patients involuntarily hospitalized and treated with algorithm-based pharmacotherapy: Secondary analysis of an observational study.
Topics: Administration, Oral; Adult; Algorithms; Antipsychotic Agents; Clozapine; Commitment of Mentally Ill; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Methotrimeprazine; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Failure; Treatment Outcome | 2019 |